We specialize in cancer immunotherapy by creating multi-specific antibodies that enable the pursuit of novel therapeutic strategies. With our proprietary MATCH technology platform, we are fueling a new wave of multi-specific drug candidates engineered with versatility and developability in mind.

Cooperation possibilities

Numab offers its discovery and development capabilities to industry partners who are looking for innovative antibody-based products. For further information please contact partnering@numab.com.

Facts & figures
  • Type of organization
    Private company
  • Year of foundation
  • Number of employees in Switzerland
Key business

You may also be interested in